PemBla: a Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer

PemBla: a Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer

<p><strong>Objectives:</strong> This study aimed to investigate the anti-PD-1 inhibitor pembrolizumab as a potential agent for use in non-muscle-invasive bladder cancer (NMIBC) by conducting a Phase 1 safety run-in study to assess the safety and tolerability of intravesical pembrol...

Descripció completa

Dades bibliogràfiques
Autors principals:	Woodcock, VK, Chen, J-L, Purshouse, K, Butcher, C, Collins, L, Haddon, C, Verrall, G, Elhussein, L, Roberts, C, Tarlton, A, Rei, M, Napolitani, G, Salio, M, Middleton, MR, Cerundolo, V, Crew, J, Protheroe, AS
Format:	Journal article
Idioma:	English
Publicat:	Wiley 2023

Ítems similars

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer
per: Victoria K. Woodcock, et al.
Publicat: (2023-05-01)

Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience
per: Karin Purshouse, et al.
Publicat: (2019-01-01)

The role of invariant natural killer T (iNKT) cells in modulating the lung inflammatory response during influenza A virus infection
per: McEwen-Smith, R, et al.
Publicat: (2013)

P105 (0032) A PHASE II STUDY OF PEMBROLIZUMAB (PEM) FOLLOWED BY AVD FOR FRONTLINE TREATMENT OF CLASSICAL HODGKIN LYMPHOMA (CHL): INTERIM RESULTS
Publicat: (2018-10-01)

Intravesical protrusion of giant median prostatic lobe: A case report
per: M. Duijn, et al.
Publicat: (2022-09-01)

Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non‐muscle‐invasive disease
per: Doyle, E, et al.
Publicat: (2018)

Re: Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study
per: Philippou, Y, et al.
Publicat: (2020)

Quimioterapia Tópica Intravesical
per: Miguel Srougi
Publicat: (2023-08-01)

CUERPO EXTRAÑO INTRAVESICAL
per: Orlando Lovelle Enríquez, et al.
Publicat: (2012-10-01)

Cuerpo extraño intravesical
per: Sonia Pérez Bertólez, et al.
Publicat: (2021-12-01)

Clinical outcomes of avelumab and pembrolizumab in advanced urothelial cancer: an observational multicenter retro-prospective study on patients undergoing treatment in clinical practice (AVePEm study)
per: Francesca Zacchi, et al.
Publicat: (2025-02-01)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
per: Ord, J, et al.
Publicat: (2005)

Intravesical ichthyosis: a rare case report
per: T. Hermans, et al.
Publicat: (2021-12-01)

Menin interacts directly with the homeobox-containing protein Pem.
per: Lemmens, I, et al.
Publicat: (2001)

Polioencephalomalacia (PEM) in calves associated with excess sulfur intake
per: Jéssica A. Withoeft, et al.

Effective Treatments of UTI—Is Intravesical Therapy the Future?
per: Chris J. Morris, et al.
Publicat: (2023-03-01)

Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma
per: John M. Rieth, et al.
Publicat: (2024-08-01)

Distribution of NMHC ratios in the Pacific during PEM-West B and PEM-Tropics A
per: Casso, Christopher Chay
Publicat: (2018)

Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran
per: Fatemeh Fallah, et al.
Publicat: (2014-01-01)

Detection of carbapenemases bla OXA48-bla KPC-bla NDM-bla VIM and extended-spectrum-β-lactamase bla OXA1-bla SHV-bla TEM genes in Gram-negative bacterial isolates from ICU burns patients
per: Muhammad Hayat Haider, et al.
Publicat: (2022-05-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
per: I. V. SAMOILENKO, et al.
Publicat: (2017-06-01)

Technique of Intravesical Laparoscopy for Ureteric Reimplantation to Treat VUR
per: Atul A. Thakre, et al.
Publicat: (2008-01-01)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
per: Salio, M, et al.
Publicat: (2011)

Linking inflammation to natural killer T cell activation
per: Salio, M, et al.
Publicat: (2009)

Harnessing NKT cells for therapeutic applications.
per: Cerundolo, V, et al.
Publicat: (2007)

Viral immunity: cross-priming with the help of TLR3.
per: Salio, M, et al.
Publicat: (2005)

Linking inflammation to natural killer T cell activation.
per: Mariolina Salio, et al.
Publicat: (2009-10-01)

Correction: Detection of carbapenemases bla OXA48-bla KPC-bla NDM-bla VIM and extended-spectrum-β-lactamase bla OXA1-bla SHV-bla TEM genes in Gram-negative bacterial isolates from ICU burns patients
per: Muhammad Hayat Haider, et al.
Publicat: (2022-07-01)

The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
per: Ines Bleriot, et al.
Publicat: (2022-03-01)

Co-occurrence of Carbapenemase Genes blaNDM, blaVIM, blaKPC and blaOXA-48 in Pseudomonas aeruginosa Clinical Isolates
per: Salma Mohamed, et al.
Publicat: (2023-09-01)

Intestinal DC in migrational imprinting of immune cells.
per: Stock, A, et al.
Publicat: (2013)

Intestinal DC in migrational imprinting of immune cells
per: Stock, A, et al.
Publicat: (2013)

New triazinephosphonate dopants for Nafion proton exchange membranes (PEM)
per: Fátima C. Teixeira, et al.
Publicat: (2024-07-01)

Control for PEM fuel cell
per: Chen, Chao.
Publicat: (2010)

Polymers for PEM fuel cells /
per: Pu, Hongting, author
Publicat: (2014)

Detection of blaDIM, blaAIM, blaGIM, blaNDM and blaVIM Genes among Acinetobacter baumannii strains isolated from hospitalized patients in Tehran hospitals, Iran
per: Hossein Goudarzi, et al.
Publicat: (2016-02-01)

Pembrolizumab-induced rash in a patient with angiosarcoma
per: Justin Qian, BA, et al.
Publicat: (2022-11-01)

The Frequency of blaVIM, blaIMP, blaKPC and blaNDM Carbapenemase Genes in Clinical Isolates of Klebsiella Pneumoniae in Kermanshah Medical Centers
per: A Zare, et al.
Publicat: (2015-11-01)

Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma
per: Purshouse, K, et al.
Publicat: (2019)

Hypertrophic Lichen Planus associated with Pembrolizumab
per: M. Sato-Sano, et al.
Publicat: (2024-01-01)